Brainomix Launches Award-Winning Next Generation Stroke AI Platform with Novel Net Water Uptake Technology at the International Stroke Conference
17.03.2026 - 23:49:57 | prnewswire.co.ukAbout Brainomix
Brainomix is a global pioneer in AI medical imaging, enabling precision medicine for better treatment decisions in stroke and lung fibrosis. Its flagship product, Brainomix 360 Stroke, is the world's first fully automated AI-imaging platform, designed for acute stroke assessment at all points of the patient pathway, facilitating more confident treatment and transfer decisions for patients in all hospitals, regardless of local resources or expertise. Brainomix 360 e-Lung technology applies AI-driven CT biomarkers to identify, monitor, and predict disease progression in pulmonary fibrosis. Founded as a spinout from the?University of?Oxford, Brainomix has offices in the UK,?Ireland?and the?USA, and operations in more than 20 countries.
To learn more about Brainomix and its technology visit www.brainomix.com, and follow us on Twitter, LinkedIn and Facebook.
Contacts
Jeff Wyrtzen, Chief Marketing Officer
jwyrtzen@brainomix.com
T +44 (0)1865 582730
US Media Enquiries
Jason Braco, Ph.D.
LifeSci Communications
jbraco@lifescicomms.com
UK & Europe Media Enquiries
Sue Charles
Charles Consultants
sue@charles-consultants.com
Photo - https://mma.prnewswire.com/media/2874606/Brainomix_360.jpg
Logo - https://mma.prnewswire.com/media/1989193/5746793/Brainomix_Logo.jpg

Hol dir jetzt den Wissensvorsprung der Aktien-Profis.
Für. Immer. Kostenlos.

